Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Latent tuberculosis screening and treatment among asylum seekers: a mixed methods study.

Spruijt I, Tesfay Haile D, Suurmond J, van den Hof S, Koenders M, Kouw P, van Noort N, Toumanian S, Cobelens F, Goosen S, Erkens C.

Eur Respir J. 2019 Sep 19. pii: 1900861. doi: 10.1183/13993003.00861-2019. [Epub ahead of print]

PMID:
31537698
2.

Implementation of latent tuberculosis infection screening and treatment among newly arriving immigrants in the Netherlands: A mixed methods pilot evaluation.

Spruijt I, Erkens C, Suurmond J, Huisman E, Koenders M, Kouw P, Toumanian S, Cobelens F, van den Hof S.

PLoS One. 2019 Jul 1;14(7):e0219252. doi: 10.1371/journal.pone.0219252. eCollection 2019.

3.

Building a European database to gather multi-country evidence on active and latent TB screening for migrants.

Öhd JN, Lönnroth K, Abubakar I, Aldridge RW, Erkens C, Jonsson J, Marchese V, Matteelli A, Menezes D, Zenner D, Hergens MP.

Int J Infect Dis. 2019 Mar;80S:S45-S49. doi: 10.1016/j.ijid.2019.02.041. Epub 2019 Feb 28.

4.

Active case finding and treatment adherence in risk groups in the tuberculosis pre-elimination era.

Gupta RK, Lipman M, Story A, Hayward A, de Vries G, van Hest R, Erkens C, Rangaka MX, Abubakar I.

Int J Tuberc Lung Dis. 2018 May 1;22(5):479-487. doi: 10.5588/ijtld.17.0767. Review.

PMID:
29663951
5.

Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis.

Fregonese F, Ahuja SD, Akkerman OW, Arakaki-Sanchez D, Ayakaka I, Baghaei P, Bang D, Bastos M, Benedetti A, Bonnet M, Cattamanchi A, Cegielski P, Chien JY, Cox H, Dedicoat M, Erkens C, Escalante P, Falzon D, Garcia-Prats AJ, Gegia M, Gillespie SH, Glynn JR, Goldberg S, Griffith D, Jacobson KR, Johnston JC, Jones-López EC, Khan A, Koh WJ, Kritski A, Lan ZY, Lee JH, Li PZ, Maciel EL, Galliez RM, Merle CSC, Munang M, Narendran G, Nguyen VN, Nunn A, Ohkado A, Park JS, Phillips PPJ, Ponnuraja C, Reves R, Romanowski K, Seung K, Schaaf HS, Skrahina A, Soolingen DV, Tabarsi P, Trajman A, Trieu L, Banurekha VV, Viiklepp P, Wang JY, Yoshiyama T, Menzies D.

Lancet Respir Med. 2018 Apr;6(4):265-275. doi: 10.1016/S2213-2600(18)30078-X. Erratum in: Lancet Respir Med. 2018 Apr 18;:.

PMID:
29595509
6.

Evaluation of tuberculosis screening of immigrants in the Netherlands.

van de Berg S, Erkens C, van Rest J, van den Hof S, Kamphorst M, Keizer S, de Vries G.

Eur Respir J. 2017 Oct 12;50(4). pii: 1700977. doi: 10.1183/13993003.00977-2017. Print 2017 Oct. No abstract available.

7.

Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points.

Lönnroth K, Mor Z, Erkens C, Bruchfeld J, Nathavitharana RR, van der Werf MJ, Lange C.

Int J Tuberc Lung Dis. 2017 Jun 1;21(6):624-637. doi: 10.5588/ijtld.16.0845. Review.

PMID:
28482956
8.

Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands.

Erkens CG, Slump E, Verhagen M, Schimmel H, Cobelens F, van den Hof S.

Eur Respir J. 2016 Nov;48(5):1420-1428. doi: 10.1183/13993003.01157-2016. Epub 2016 Oct 6.

9.

Variation in policy and practice of adolescent tuberculosis management in the WHO European Region.

Blok N, van den Boom M, Erkens C, Dara M, van den Hof S.

Eur Respir J. 2016 Sep;48(3):943-6. doi: 10.1183/13993003.00704-2016. Epub 2016 Jul 28. No abstract available.

10.

Monitoring latent tuberculosis infection diagnosis and management in the Netherlands.

Erkens CG, Slump E, Verhagen M, Schimmel H, de Vries G, Cobelens F, van den Hof S.

Eur Respir J. 2016 May;47(5):1492-501. doi: 10.1183/13993003.01397-2015. Epub 2016 Feb 25. Erratum in: Eur Respir J. 2017 Jan 25;49(1):.

11.

[Tuberculosis among asylum-seekers in the Netherlands: a descriptive study among the two largest groups of asylum-seekers].

de Vries G, Gerritsen RF, van Burg JL, Erkens CG, van Hest NA, Schimmel HJ, van Dissel JT.

Ned Tijdschr Geneeskd. 2016;160:D51. Dutch.

PMID:
26980468
12.

The epidemiology of childhood tuberculosis in the Netherlands: still room for prevention.

Erkens CG, de Vries G, Keizer ST, Slump E, van den Hof S.

BMC Infect Dis. 2014 May 31;14:295. doi: 10.1186/1471-2334-14-295.

13.

Extent and origin of resistance to antituberculosis drugs in the Netherlands, 1993 to 2011.

Ruesen C, van Gageldonk-Lafeber AB, de Vries G, Erkens CG, van Rest J, Korthals Altes H, de Neeling H, Kamst M, van Soolingen D.

Euro Surveill. 2014 Mar 20;19(11). pii: 20738.

14.

Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands.

Erkens CG, Dinmohamed AG, Kamphorst M, Toumanian S, van Nispen-Dobrescu R, Alink M, Oudshoorn N, Mensen M, van den Hof S, Borgdorff M, Verver S.

Int J Tuberc Lung Dis. 2014 Apr;18(4):413-20. doi: 10.5588/ijtld.13.0589.

PMID:
24670695
15.

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.

Lange C, Abubakar I, Alffenaar JW, Bothamley G, Caminero JA, Carvalho AC, Chang KC, Codecasa L, Correia A, Crudu V, Davies P, Dedicoat M, Drobniewski F, Duarte R, Ehlers C, Erkens C, Goletti D, Günther G, Ibraim E, Kampmann B, Kuksa L, de Lange W, van Leth F, van Lunzen J, Matteelli A, Menzies D, Monedero I, Richter E, Rüsch-Gerdes S, Sandgren A, Scardigli A, Skrahina A, Tortoli E, Volchenkov G, Wagner D, van der Werf MJ, Williams B, Yew WW, Zellweger JP, Cirillo DM; TBNET.

Eur Respir J. 2014 Jul;44(1):23-63. doi: 10.1183/09031936.00188313. Epub 2014 Mar 23.

16.

First joint meeting of three European tuberculosis networks.

van der Werf MJ, Erkens C, Gebhard A, Voitzwinkler F, Dara M.

Euro Surveill. 2013 Sep 12;18(37). pii: 20583. No abstract available.

17.

Comparative study of IS6110 restriction fragment length polymorphism and variable-number tandem-repeat typing of Mycobacterium tuberculosis isolates in the Netherlands, based on a 5-year nationwide survey.

de Beer JL, van Ingen J, de Vries G, Erkens C, Sebek M, Mulder A, Sloot R, van den Brandt AM, Enaimi M, Kremer K, Supply P, van Soolingen D.

J Clin Microbiol. 2013 Apr;51(4):1193-8. doi: 10.1128/JCM.03061-12. Epub 2013 Jan 30.

18.

Tuberculosis treatment outcome monitoring in European Union countries: systematic review.

van Hest R, Ködmön C, Verver S, Erkens CG, Straetemans M, Manissero D, de Vries G.

Eur Respir J. 2013 Mar;41(3):635-43. doi: 10.1183/09031936.00030612. Epub 2012 Jul 12. Review.

19.

Tuberculosis seasonality in the Netherlands differs between natives and non-natives: a role for vitamin D deficiency?

Korthals Altes H, Kremer K, Erkens C, van Soolingen D, Wallinga J.

Int J Tuberc Lung Dis. 2012 May;16(5):639-44. doi: 10.5588/ijtld.11.0680. Epub 2012 Mar 9.

PMID:
22410705
20.

Coverage and yield of tuberculosis contact investigations in the Netherlands.

Mulder C, van Deutekom H, Huisman EM, Meijer-Veldman W, Erkens CG, van Rest J, Borgdorff MW, van Leth F.

Int J Tuberc Lung Dis. 2011 Dec;15(12):1630-7. doi: 10.5588/ijtld.11.0027.

PMID:
22118170
21.

Missed opportunities in tuberculosis control in The Netherlands due to prioritization of contact investigations.

Mulder C, Erkens CG, Kouw PM, Huisman EM, Meijer-Veldman W, Borgdorff MW, van Leth F.

Eur J Public Health. 2012 Apr;22(2):177-82. doi: 10.1093/eurpub/ckr017. Epub 2011 Mar 7.

PMID:
21382971
22.

Risk of travelling to the country of origin for tuberculosis among immigrants living in a low-incidence country.

Kik SV, Mensen M, Beltman M, Gijsberts M, van Ameijden EJ, Cobelens FG, Erkens C, Borgdorff MW, Verver S.

Int J Tuberc Lung Dis. 2011 Jan;15(1):38-43.

PMID:
21276294
23.

A comparative examination of tuberculosis immigration medical screening programs from selected countries with high immigration and low tuberculosis incidence rates.

Alvarez GG, Gushulak B, Abu Rumman K, Altpeter E, Chemtob D, Douglas P, Erkens C, Helbling P, Hamilton I, Jones J, Matteelli A, Paty MC, Posey DL, Sagebiel D, Slump E, Tegnell A, Valín ER, Winje BA, Ellis E.

BMC Infect Dis. 2011 Jan 4;11:3. doi: 10.1186/1471-2334-11-3.

24.

Tuberculosis contact investigation in low prevalence countries: a European consensus.

Erkens CG, Kamphorst M, Abubakar I, Bothamley GH, Chemtob D, Haas W, Migliori GB, Rieder HL, Zellweger JP, Lange C.

Eur Respir J. 2010 Oct;36(4):925-49. doi: 10.1183/09031936.00201609.

25.

The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement.

Solovic I, Sester M, Gomez-Reino JJ, Rieder HL, Ehlers S, Milburn HJ, Kampmann B, Hellmich B, Groves R, Schreiber S, Wallis RS, Sotgiu G, Schölvinck EH, Goletti D, Zellweger JP, Diel R, Carmona L, Bartalesi F, Ravn P, Bossink A, Duarte R, Erkens C, Clark J, Migliori GB, Lange C.

Eur Respir J. 2010 Nov;36(5):1185-206. doi: 10.1183/09031936.00028510. Epub 2010 Jun 7.

26.

Progress towards tuberculosis elimination: secular trend, immigration and transmission.

Borgdorff MW, van den Hof S, Kremer K, Verhagen L, Kalisvaart N, Erkens C, van Soolingen D.

Eur Respir J. 2010 Aug;36(2):339-47. doi: 10.1183/09031936.00155409. Epub 2009 Dec 8.

27.

Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts.

Kik SV, Franken WP, Mensen M, Cobelens FG, Kamphorst M, Arend SM, Erkens C, Gebhard A, Borgdorff MW, Verver S.

Eur Respir J. 2010 Jun;35(6):1346-53. doi: 10.1183/09031936.00098509. Epub 2009 Oct 19.

28.

Projection of the number of patients with tuberculosis in the Netherlands in 2030.

van Leth F, Kalisvaart NA, Erkens CG, Borgdoff MW.

Eur J Public Health. 2009 Aug;19(4):424-7. doi: 10.1093/eurpub/ckp042. Epub 2009 Apr 8.

PMID:
19357241
29.

[Estimation of the incidence of tuberculosis in The Netherlands in 2030].

van Leth F, Kalisvaart NA, Erkens CG, Borgdorff MW.

Ned Tijdschr Geneeskd. 2008 Mar 15;152(11):616-21. Dutch.

PMID:
18410022
30.

Coverage and yield of entry and follow-up screening for tuberculosis among new immigrants.

Erkens C, Slump E, Kamphorst M, Keizer S, van Gerven PJ, Bwire R, Berkel M, Borgdorff MW, Verver S.

Eur Respir J. 2008 Jul;32(1):153-61. doi: 10.1183/09031936.00137907. Epub 2008 Feb 20.

Supplemental Content

Loading ...
Support Center